Evgen Pharma plc (AIM: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has told DirectorsTalk about the appointment of Dr Hamina J Patel
Evgen Pharma Plc (LON:EVG) CEO Dr Stephen Franklin discusses SFX-01 and it’s multiple applications, the “broccoli drug” and what is after SFX-01. Stephen, the founder of Evgen Pharma, has over
Evgen Pharma’s Dr Stephen Franklin provides a summary of the Evgen proposition following their first interim results as a quoted company
Evgen Pharma Plc (LON:EVG) CEO Dr Stephen Franklin takes this opportunity after the first Interim results as a quoted company to summerise the Evgen proposition. The Interim results article
Northland Capital partners view: Evgen has had a transformative year-to-date. The group is now fully funded to achieve its product development goals. The group’s core technology allows for the production
Evgen Pharma plc (AIM: EVG), the clinical stage drug development company focused on the treatment of cancer and neurological conditions, has given DirectorsTalk its unaudited interim results for the six
Healthcare: We highlight our top Healthcare pick for this month, namely Evgen Pharma* (EVG.L, BUY, PT 79p). Evgen’s core technology allows for the production of a stable version of sulforaphane,
Northland Capital Partners Deputy Head of Research, Vadim Alexandre talks to DirectorsTalk about it’s bullish initiation note on Evgen Pharma Plc (LON:EVG). Vadim discusses the attributes liked about Evgen, why
Northland Capital partners view on Evgen Pharma PLC: Evgen’s core technology allows for the production of a stable version of sulforaphane, a potential treatment for various conditions, including several cancers
Yesterday, Evgen Pharma informed that it has bought exclusive worldwide licensing rights to a wide range of novel compounds from the Spanish National Research Council (CSIC) and the University of
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
